STOCK TITAN

Debra Perelman (BBBY) adds 32,174 shares and new RSU grant in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bed Bath & Beyond director Debra Golding Perelman reported equity compensation activity, acquiring shares through RSU vesting and receiving new awards. On May 15, 2026, 26,873 restricted stock units converted into the same number of common shares at a price of $0.00, increasing her direct common stock holdings to 32,174 shares.

On May 14, 2026, she received a grant of 35,181 restricted stock units, each representing a contingent right to one common share that vests at the close of business on May 14, 2027. She also holds 530 common stock warrants that were originally issued on October 7, 2025 in a pro-rata distribution to all common shareholders, each exercisable for one common share at an exercise price of $15.50 per warrant until October 7, 2026.

Positive

  • None.

Negative

  • None.
Insider Perelman Debra Golding
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 26,873 $0.00 --
Exercise Common Stock 26,873 $0.00 --
Grant/Award Restricted Stock Units 35,181 $0.00 --
Grant/Award Common Stock Warrant 530 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 32,174 shares (Direct, null); Common Stock Warrant — 530 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
RSUs converted to shares 26,873 shares Common stock from RSU vesting on May 15, 2026 at $0.00
Shares held after transaction 32,174 shares Direct Bed Bath & Beyond common stock following RSU conversion
New RSU grant 35,181 units Restricted stock units granted May 14, 2026, vesting May 14, 2027
Warrants held 530 warrants Common stock warrants issued October 7, 2025 as pro-rata distribution
Warrant exercise price $15.50 per warrant Each warrant exercisable for one common share until October 7, 2026
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Common Stock Warrant financial
"Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock."
A common stock warrant is a tradable right that lets its holder buy a company’s common shares at a fixed price within a set time period. For investors it acts like a long‑dated option: it can magnify gains if the share price rises above the fixed price, but it also creates potential dilution because new shares are issued when warrants are used, which can reduce the value of existing shares.
exercise price financial
"Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Section 16 regulatory
"This distribution was exempt from immediate reporting under Section 16."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Perelman Debra Golding

(Last)(First)(Middle)
433 ASCENSION WAY
3RD FLOOR

(Street)
MURRAY UTAH 84123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND, INC. [ BBBY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M26,873A(1)32,174D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)05/14/2026A35,181 (2) (2)Common Stock35,181$035,181(2)D
Restricted Stock Units(1)05/15/2026M26,873 (1) (1)Common Stock26,873$00(1)D
Common Stock Warrant$15.510/07/2025A530(3)12/03/202510/07/2026Common Stock530$0530D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
2. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
3. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
/s/ Christina Wheeler, Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Debra Perelman report in this Bed Bath & Beyond (BBBY) Form 4?

Debra Perelman reported equity compensation activity, including RSU vesting into common shares and new RSU and warrant holdings. The filing shows non-cash acquisitions, with no open-market stock sales or purchases disclosed in these transactions.

How many Bed Bath & Beyond shares does Debra Perelman hold after these transactions?

After the May 15, 2026 RSU conversion, Debra Perelman directly holds 32,174 shares of Bed Bath & Beyond common stock. This reflects the addition of 26,873 shares delivered upon restricted stock units vesting at a conversion price of $0.00 per share.

What restricted stock unit grants are disclosed for Debra Perelman at BBBY?

The filing shows a grant of 35,181 restricted stock units on May 14, 2026. Each unit equals one common share and vests at the close of business on May 14, 2027, with shares delivered promptly after vesting according to the footnote disclosure.

When did Debra Perelman’s Bed Bath & Beyond RSUs vest into common stock?

A block of 26,873 restricted stock units vested at the close of business on May 15, 2026. Upon vesting, an equal number of Bed Bath & Beyond common shares were delivered to Debra Perelman, increasing her direct stock ownership to 32,174 shares.

What details are provided about Debra Perelman’s Bed Bath & Beyond stock warrants?

She holds 530 common stock warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all common shareholders. Each warrant allows purchase of one common share at a $15.50 exercise price and expires on October 7, 2026.

Were there any Bed Bath & Beyond stock sales by Debra Perelman in this Form 4?

The Form 4 does not report any stock sales. All transactions are coded as awards or derivative exercises, including RSU vesting into common stock and warrant or RSU grants, with no open-market sale codes such as “S” disclosed in this filing.